Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain

Kidney Blood Press Res. 2007;30(6):400-7. doi: 10.1159/000108626. Epub 2007 Sep 20.

Abstract

Background/aims: The role of endothelin (ET) in cardiovascular remodeling was investigated by treating uninephrectomized spontaneously hypertensive rats of the stroke-prone strain (UNX-SHRsp) on normal- or high (3%)-salt diet with the selective ET(A) receptor blocker LU 135252.

Methods: SHRsp on normal or high salt were sham-operated (n = 10/11) or UNX; UNX received no treatment (n = 10/15) or 100 mg/kg body weight LU 135252 (n = 10/10). Systolic blood pressure (BP) was measured weekly. After perfusion fixation the heart and the aorta were analyzed using quantitative morphological and stereological techniques.

Results: No effect was seen in normal-salt groups. In high-salt animals UNX caused left ventricular (LV) hypertrophy which was prevented by LU 135252 (p < 0.001). LU 135252 only lowered BP during the last 2 weeks of the 12-week experiment. UNX showed hypertrophic remodeling of intramyocardial arterioles. Treatment with LU 135252 caused lower wall:lumen ratio and wall thickness of LV intramyocardial arterioles (p < 0.01). In the descending thoracic aorta UNX caused thickening of the media. The media area and the wall:lumen ratio were lower in UNX + LU 135252 as compared to untreated UNX (p < 0.01 and p < 0.05, respectively).

Conclusion: In SHRsp UNX causes hypertrophic cardiovascular remodeling only in the presence of salt loading. These effects are largely BP-independent and prevented by ET(A) receptor blockade.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / pathology
  • Arterioles / pathology
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Body Weight / physiology
  • Cardiovascular System / drug effects*
  • Cardiovascular System / physiopathology
  • Disease Models, Animal
  • Endothelin A Receptor Antagonists*
  • Genetic Predisposition to Disease / genetics*
  • Hypertrophy
  • Male
  • Nephrectomy*
  • Phenylpropionates / pharmacology*
  • Pyrimidines / pharmacology*
  • Rats
  • Rats, Inbred SHR
  • Stroke / genetics*
  • Stroke / physiopathology
  • Tunica Media / pathology
  • Ventricular Remodeling / drug effects*

Substances

  • Endothelin A Receptor Antagonists
  • Phenylpropionates
  • Pyrimidines
  • darusentan